LDH-IN-1 is a potent, pyrazole-derived inhibitor of human lactate dehydrogenase isoforms LDHA and LDHB, exhibiting IC50 values of 32 nM and 27 nM, respectively. This compound is a valuable research tool for investigating cancer metabolism, particularly in in vitro studies targeting glycolysis-dependent tumor cell proliferation.
